HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fabiola Wilting Selected Research

Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)

3/2010Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fabiola Wilting Research Topics

Disease

3Cardiac Arrhythmias (Arrythmia)
11/2021 - 12/2017
2Polymorphic catecholergic ventricular tachycardia
11/2021 - 12/2017
1Ventricular Tachycardia
12/2017
1Cardiovascular Diseases (Cardiovascular Disease)
12/2017
1Neoplasms (Cancer)
03/2010
1Neuroblastoma
03/2010

Drug/Important Bio-Agent (IBA)

2Anti-Arrhythmia AgentsIBA
11/2021 - 12/2017
1kaempferolIBA
12/2017
1Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
12/2017
1Vascular Endothelial Growth Factor DIBA
03/2010
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
03/2010
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
03/2010
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2010

Therapy/Procedure

1Therapeutics
01/2020
1Drug Therapy (Chemotherapy)
03/2010
1Radiotherapy
03/2010